JAZZ PHARMACEUTICALS, INC

Jazz Pharmaceuticals, Inc. specializes in the manufacturing and supply of specialized pharmaceutical preparations, with deep expertise in the production of controlled oral solutions for central nervous system disorders. Their core capabilities center on GMP-compliant manufacturing of complex formulations, including sodium oxybate-based therapeutics such as Xywav and Xyrem, requiring precise compounding, stability validation, and strict chain-of-custody protocols. The company demonstrates advanced proficiency in bulk pharmacy operations, sterile solution formulation, and regulatory-compliant packaging for high-acuity, chronic-use medications. Their technical edge lies in managing tightly controlled substance logistics, ensuring consistent potency, purity, and patient safety under DEA and FDA oversight. The Department of Veterans Affairs is the sole federal agency with which Jazz Pharmaceuticals has an established contracting relationship, consistently procuring specialty pharmaceuticals to support veteran care programs. These engagements reflect a long-standing, recurring partnership focused on supplying FDA-approved, high-integrity medications for neurological and sleep-related conditions, indicating a trusted role in VA’s specialty pharmacy network for complex therapeutic needs. The primary NAICS code 325412 reflects active involvement in pharmaceutical preparation manufacturing, specifically the formulation and production of finished dosage forms for clinical use. This positions the company within the niche segment of specialty pharma manufacturing, serving patients requiring customized, high-cost, or controlled medications with stringent quality controls. Their market focus is firmly on therapeutics for rare or chronic neurological indications, distinguishing them from broad-spectrum generic manufacturers. Jazz Pharmaceuticals, Inc. operates as a privately held entity headquartered in Palo Alto, California, with no publicly disclosed government certifications. The company’s geographic presence is centered in California, with its operational footprint aligned to federal pharmaceutical supply chains serving VA and other U.S. government healthcare systems. Their business model emphasizes regulatory rigor, supply reliability, and therapeutic specialization over volume production.